You are here

Vertex Pharmaceuticals

5 Experimental New Drugs That Could Be Worth $47 Billion

5 Experimental New Drugs That Could Be Worth $47 Billion

Motley Fool

VX-659 + tezacaftor + ivacaftor

Vertex Pharmaceuticals

Flag link:

Vertex doubles size of cystic fibrosis drug discovery site

Vertex doubles size of cystic fibrosis drug discovery site

Fierce Biotech

Vertex Pharmaceuticals

drug development

cystic fibrosis

Flag link:

Big Biotech Set for Earnings Blowout?

Big Biotech Set for Earnings Blowout?

Barron's

Gilead Sciences

Vertex Pharmaceuticals

Flag link:

FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

Xconomy

sickle cell disease

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Vertex Pharma Tops Quarterly Views On Strong Cystic Fibrosis Drug Sales

Vertex Pharma Tops Quarterly Views On Strong Cystic Fibrosis Drug Sales

Investors Business Daily

Vertex Pharmaceuticals

Flag link:

Immunotherapies, biosimilars to dominate next week of earnings

Immunotherapies, biosimilars to dominate next week of earnings

Biopharma Dive

Bristol-Myers Squibb

Vertex Pharmaceuticals

Flag link:

Why A Biopharma Buying Spree May Target AstraZeneca, Bristol

Why A Biopharma Buying Spree May Target AstraZeneca, Bristol

Investors Business Daily

Bristol-Myers Squibb

Vertex Pharmaceuticals

Flag link:

Vertex cancels plans for CF triple combo testing in France, citing failed Orkambi negotiations

Vertex cancels plans for CF triple combo testing in France, citing failed Orkambi negotiations

Fierce Pharma

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

New approval helps Vertex's 'cleanest growth story in biotech'

New approval helps Vertex's 'cleanest growth story in biotech'

Biopharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex is still one of the top M&A targets

Vertex is still one of the top M&A targets

GoinPharma

Vertex Pharmaceuticals

Flag link:

Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Forbes

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Biotech of the Year: Vertex Pharmaceuticals

Biotech of the Year: Vertex Pharmaceuticals

BioPharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

5 Top Biotech Stocks

5 Top Biotech Stocks

Motley Fool

Gilead Sciences

Ligand Pharmaceuticals

Vertex Pharmaceuticals

Flag link:

Vertex Pops As Analyst Questions Whether Rival Has 'Viable Drug'

Vertex Pops As Analyst Questions Whether Rival Has 'Viable Drug'

Investors Business Daily

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Pharmaceuticals Incorporated: One Eye on Earnings, One on the Pipeline

Vertex Pharmaceuticals Incorporated: One Eye on Earnings, One on the Pipeline

Motley Fool

Vertex Pharmaceuticals

Flag link:

Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?

Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Gilead Sciences

tezecaftor/ivacaftor

Flag link:

Vertex Plans To Eradicate Cystic Fibrosis, And Go From There

Vertex Plans To Eradicate Cystic Fibrosis, And Go From There

Investors Business Daily

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

3 Monster Biotech Stocks in the Making

3 Monster Biotech Stocks in the Making

Motley Fool

Vertex Pharmaceuticals

Flag link:

Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.

Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.

Yahoo/Zacks.com

Vertex Pharmaceuticals

cystic fibrosis

priority review

tezacaftor/ivacaftor

Flag link:

Vertex wins new Kalydeco approval, ups sales forecast

Vertex wins new Kalydeco approval, ups sales forecast

BioPharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Pages